CD274 and neoplasm: AMPNstreatment induced PD-L1 increases that could increase the responserate to anti-PD-L1 or anti-PD-1 therapy by increasing tumor-directedimmune responses to enhance the elimination of primary tumors andprevent tumor recurrence.10,50